Inotuzumab Ozogamicin Market Size, Competitive Landscape, Revenue...

ha aggiunto una foto Health

2023-07-11 09:01:29 - Translate -

Inotuzumab Ozogamicin Market Size, Competitive Landscape, Revenue Analysis, 2022–2027

Inotuzumab Ozogamicin Market is a combination of a monoclonal antibody and a chemotherapy drug used to treat B-cell acute lymphoblastic leukemia (ALL) that has relapsed or is unresponsive to treatment. The FDA has approved inotuzumab ozogamicin for treating adults with relapsed or refractory B-cell precursor ALL. The antibody component of inotuzumab ozogamicin binds to CD22 receptors, which...

0 Commenti 0 condivisioni 6K Views 0 Anteprima